Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | RVX2135 |
Synonyms | |
Therapy Description |
RVX2135 is a small molecule inhibitor of BET that binds to BRD2, BRD3, and BRD4, and may result in inhibition of cell proliferation, cell cycle arrest, and induced apoptosis (AACR; Cancer Res 2013;73(8 Suppl):Abstract nr LB-92, PMID: 24979794). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RVX2135 | BET Inhibitor (Pan) 32 | RVX2135 is a small molecule inhibitor of BET that binds to BRD2, BRD3, and BRD4, and may result in inhibition of cell proliferation, cell cycle arrest, and induced apoptosis (AACR; Cancer Res 2013;73(8 Suppl):Abstract nr LB-92, PMID: 24979794). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|